|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, January 06, 2020 ) Increasing prevalence of Infectious diseases such as Influenza, HPV, Hepatitis, HIV and Tuberculosis despite rise in sanitation practices globally. In the past, antimicrobials medicines were used to fight powerful infectious disease but slowly in today's time antimicrobial agent is not able to give the desired results because the problem of drug resistant occurs in many people across the world. Nowadays, a new diagnostic procedure is being followed to fight infectious disease like molecular diagnostic test is very effective which is quite fast and precise. The number of cancer patients is increasing very fast, so it is believed that in the coming time the molecular diagnostic test market will be growing at rapid pace. Global Molecular Diagnostics Market is likely to surpass US$ 22.5 Billion by the end of year 2025.
There are various reasons that will propel the market growth in forecast year; rising incidence rate of infectious disease, increasing incidence rate of cancer of all type, increasing people awareness regarding molecular diagnostic, rapid technological growth, widely acceptance of personalized medicine, rising healthcare infrastructure, increasing healthcare per capita expenditure across the developed and developing nation, accuracy of diagnosis, growing population of cardiovascular and neurological disorder etc. In addition, increasing prevalence of genetic disorder will further boost the market in forecast period of time.
Renub Research report titled Molecular Diagnostics Market Share & Forecast, By Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMιrieux and Others) provides a complete analysis of Molecular Diagnostics Market.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=global-molecular-diagnostics-market-and-future-forecast-2010-2014-334-p.php
Market Insight by Application
The report provides comprehensive analysis of molecular diagnostic test market by application into ten parts: Infectious Diseases, Genetic Testing, Blood Screening, Oncology, HLA (Tissue Typing), Microbiology, Neurological Diseases, Pharmacogenomics, Cardiovascular Diseases, and Others. This report also provides key opportunities market and specific factors are given by each application market.
Market Insight by Technology
Here the market is fragmented into six parts; PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others. Besides, many factors are analyzed that influence the growth, challenges and opportunities of market in technological context.
Market Insight by End User
The report provides complete insight of market by End User segments: Hospitals & Academic Laboratories, Clinics & Commercial Laboratories and Others. According to Renub Research Analysis, Hospitals & Academic Laboratories will hold the largest market in global molecular diagnostic test market in forecast period of time.
Market Insight by Regions
This report covers the complete regional profile by 10 geographical market; United States, Europe, India, China, Japan, Brazil, South Korea, Mexico, Russia and Rest of World (ROW).
Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=global-molecular-diagnostics-market-and-future-forecast-2010-2014-334-p.php
By Application
Infectious Diseases
Blood Screening
Oncology
Genetic Testing
HLA (Tissue Typing)
Microbiology
Cardiovascular Diseases
Neurological Diseases
Pharmacogenomics
Others
By Technology
PCR
Transcription-Mediated Amplification (TMA)
Hybridiazation (In-situ Hybridiazation & FISH)
DNA Sequencing & NGS
Microarray
Others
By End User
Hospitals & Academic Laboratories
Clinics & Commercial Laboratories
Others
By Regions
United States
Europe (Expect Russia)
India
China
Japan
Brazil
South Korea
Mexico
Russia
Rest of World
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com
Browse Related Reports:
Drug Abuse Testing Market @ https://www.renub.com/drugs-abuse-testing-market-p.php
Next Generation Sequencing Market @ https://www.renub.com/next-generation-sequencing-market-p.php
About Us
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Contact Us
Renub Research
Phone: +1-678-302-0700
Email: info@renub.com
Website: www.renub.com
Follow us on LinkedIn: www.linkedin.com/company/renub-research
Renub Research
Rajat Gupta
Market Research, Bus
rajat.gupta@renub.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
